MIP PHARMA DANMARK ApS: Financial statements 2024
CVR: 32886280
Source: annual report 2024, Danish Business Authority
01/07/2023 – 30/06/2024
MIP PHARMA DANMARK ApS (CVR 32886280) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -92,378 and a net result of DKK -109,135 compared with DKK -65,052 the year before. Equity in the 2024 report amounted to DKK -561,038.
- Gross Profit
- DKK -92,378
- Profit/Loss
- DKK -109,135
- Equity
- DKK -561,038
- Total Assets
- DKK 38,363
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -92 t. | -109 t. | -561 t. | - |
| 2023 | - | -39 t. | -65 t. | -452 t. | - |
| 2022 | - | -48 t. | -79 t. | -387 t. | - |
| 2021 | - | -39 t. | -53 t. | -308 t. | - |
| 2020 | - | -24 t. | -38 t. | -255 t. | 0 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of October 1, 2024, Peter Johannes Lenbet is registered as director of MIP PHARMA DANMARK ApS.
As of September 30, 2024, Martin Osterhues has stepped down as director of MIP PHARMA DANMARK ApS.
About MIP PHARMA DANMARK ApS
MIP PHARMA DANMARK ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2010. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Jochen Steinhage. The company is owned by MIP Pharma GmbH. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -129,052 and a net result of DKK -155,646 compared with DKK -109,135 the year before. Equity in the 2025 report amounted to DKK -716,683.